UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
Amendment No.: *
Name of Issuer: PHARMAKINETICS LABORATORIES, INC.
Title of Class of Securities: Common Stock, $.01 par value
CUSIP Number: 52-1067519
(Name, Address and Telephone Number of Person
Authorized To Receive Notices and Communications)
Mr. Dennis Chase
P.O. Box 248, North Lake, WI 53064
(262)870-6707
(Date of Event which Requires Filing of this Statement)
January 4, 2000
If the filing person has previously filed a statement on Schedule
13G to report the acquisition which is the subject of this
Schedule 13D, and is filing this schedule because of
Rule 13d-1(b)(3) or (4), check the following box [ ].
Check the following box if a fee is being paid with this
statement []. (A fee is not required only if the filing person:
(1) has a previous statement on file reporting beneficial
ownership of more than five percent of the class of securities
described in Item 1; and (2) has filed no amendment subsequent
thereto reporting beneficial ownership of five percent or less of
class. See Rule 13d-7).
*The remainder of this cover page shall be filled out for a
reporting person's initial filing on this form with respect to
the subject class of securities, and for any subsequent amendment
containing information which would alter the disclosures provided
in a prior cover page.
The information required in the remainder of this cover page
shall not be deemed to be "filed" for the purpose of Section 18
of the Securities Exchange Act of 1934 ("Act") or otherwise
subject to the liabilities of that section of the Act but shall
be subject to all other provisions of the Act (however, see the
Notes).
CUSIP No. 52-1067519
1. Name of Reporting Person
S.S. or I.R.S. Identification No. of Above Person
Dennis Chase, ###-##-####
2. Check the Appropriate Box if a Member or a Group
a. x
b.
3. SEC Use Only
4. Source of Funds
Personal
5. Check if Disclosure of Legal Proceedings is Required Pursuant
to Items 2(d) or 2(e)
6. Citizenship or Place of Organization
Wisconsin
Number of Shares Beneficially Owned by Each Reporting Person
With:
7. Sole Voting Power:
290,500
8. Shared Voting Power:
None.
9. Sole Dispositive Power:
290,500
10. Shared Dispositive Power:
None.
11. Aggregate Amount Beneficially Owned
290,500
12. Percent of Class Represented by Amount in Row (11)
11.60% Basic Weighted Average
13. Type of Reporting Person
Private Investor
Item 1. Security and Issuer
This statement relates to shares of common stock, $.005
par value; authorized, 10,000,000 shares; issued in
outstanding, 2,496,129.
Item 2. Identity and Background
Private investor
Item 3. Source and Amount of Funds or Other Consideration.
Personal funds. No leverage was used to purchase
any shares.
Item 4. Purpose of Transactions.
The shares of Common Stock are being held for
investment purposes.
Item 5. Interest in Securities of Issuer.
As of the date hereof, Dennis Chase is deemed to be
the beneficial owner of 290,500 shares or 11.60% of
the total common stock outstanding.
Item 6. Contracts, Arrangements, Understandings or
Relationships with Respect to Securities of the Issuer
None.
Item 7. Material to be Filed as Exhibits.
None.
Signature
The undersigned, after reasonable inquiry and to the
best of its knowledge and belief, certifies that the
information set forth in this statement is true,
complete and correct.
January 4, 2000
Dennis Chase
By: /s/ Dennis Chase
__________________________
Dennis Chase
